1270497-54-5 Usage
General Description
3,6-dibromopyrazine-2-carbaldehyde is a chemical compound with the molecular formula C6H3Br2N2O. It is an aldehyde derivative, containing a pyrazine ring with bromine atoms attached to the 3rd and 6th carbon atoms. 3,6-dibromopyrazine-2-carbaldehyde is commonly used in organic synthesis as a building block for pharmaceuticals, agrochemicals, and materials science. Its aromatic properties and reactivity make it a valuable intermediate in the production of various chemical compounds. Additionally, 3,6-dibromopyrazine-2-carbaldehyde has shown potential as a useful reagent in the development of novel chemical reactions and processes in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1270497-54-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,0,4,9 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1270497-54:
(9*1)+(8*2)+(7*7)+(6*0)+(5*4)+(4*9)+(3*7)+(2*5)+(1*4)=165
165 % 10 = 5
So 1270497-54-5 is a valid CAS Registry Number.
1270497-54-5Relevant articles and documents
JAK kinase inhibitor, preparation method thereof, and application in the field of medicines
-
Paragraph 0230; 0233; 0236; 0237, (2019/04/10)
The application relates to a JAK kinase inhibitor, a preparation method thereof, and an application in the field of medicines and belongs to the field of medical chemistry. In the application, a series of novel small-molecular JAK inhibitors are provided and are represented as the general formula (II). The compounds have better effects and higher safety in prevention or treatment on JAK-related adaptation diseases.
INHIBITORS OF JAK
-
Page/Page column 85-86, (2011/04/18)
The present invention relates to the use of novel compounds of Formula I, wherein the variables m, n, p, q, Q, r, R, R′, X, X′, Y, Z1, Z2, and Z3 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
